Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Erectile Dysfunction × Erythropoietin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Anemia 4 Uterine Cervical Neoplasms 2 Myelodysplastic Syndromes 2 Leukemia 2 Rectal Neoplasms 1 Radiation Injuries 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms 1 Lymphoma 1 Lichen Planus, Oral 1 Leukemia, Myelomonocytic, Chronic 1 Head and Neck Neoplasms 1 Gastrointestinal Neoplasms 1 Erectile Dysfunction 1 Drug-Related Side Effects and Adverse Reactions 1

Interventions

Sildenafil Citrate 9 Tadalafil 3 Surveys and Questionnaires 2 Pentoxifylline 2 Alprostadil 2 udenafil 1 trametinib 1 sotorasib 1 selpercatinib 1 pembrolizumab 1 osimertinib 1 mirabegron 1 methyl 3-mercaptopropionimidate 1 lorlatinib 1 dabrafenib 1 cemiplimab 1 brigatinib 1 bicalutamide 1 alpha-Tocopherol 1 alectinib 1 Yoga 1 Vitamin E 1 Tamoxifen 1 Tacrolimus 1 Tablets 1 Surgical Instruments 1 Saline Solution 1 Restraint, Physical 1 Psychiatric Rehabilitation 1 Preservation, Biological 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00737893 2021-04-08

ERECT

Johns Hopkins University

Phase 2 Completed

56 enrolled 27 charts

Erectile Dysfunction, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡